期刊文献+

多囊卵巢综合征的临床表现及内分泌变化的研究分析 被引量:9

Analysis of the clinical manifestations and endocrine changes of women with polycystic ovarian syndrome
下载PDF
导出
摘要 目的探讨多囊卵巢综合征患者常见的临床表现及内分泌变化情况。方法按照随机双盲原则选取2015年1月至2015年12月于本院确诊为多囊卵巢综合征的患者80例为研究对象,入组患者均常规给予枸橼酸氯米芬联合二甲双胍。比较患者用药前后体内性激素水平变化情况及用药治疗对血糖代谢的影响。结果用药后患者空腹胰岛素水平、胰岛素抵抗指数、临床表现(卵巢体积增大、多毛、痤疮、月经紊乱)均较用药前显著改善(P<0.05),而用药前后空腹血糖水平比较差异无显著性(P>0.05)。结论枸橼酸氯米芬联合二甲双胍能够有效提高多囊卵巢综合征患者的临床疗效,纠正患者高胰岛素血症,并减少胰岛素抵抗,值得临床推广应用。 Objective To explore and research the clinical manifestations and endocrine changes of women with polycystic ovarian syndrome. Method According to the principle of random double-blind, 80 cases of patients who were diagnosed as polycystic ovarian syndrome from January 2015 to December 2015 in our hospital were selected as the objects of the study, all patients were given oral administration clomiphene citrate and metformin, compared and researched the changes of the sex hormone levels of the patients before and after medication and its influence on blood glucose metabolism. Result After treatment, fasting insulin, insulin resistance index, clinical manifestations(ovarian volume, hirsutism, acne, menstruation disorder) of the patients had significantly improved(P〈0.05), and difference of fasting blood glucose before and after treatment was not statistically significant(P〉0.05). Conclusion Applying combined drug therapy on polycystic ovarian syndrome patients not only can improve the clinical total effective rate of treatment, but also significantly improve the regulatory hormone level, it is worthy of recommendation and application.
作者 杨铧琦 康东
出处 《中国医学前沿杂志(电子版)》 2016年第7期80-82,共3页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金 四川省卫生厅科研课题资助项目(110610)
关键词 多囊卵巢综合征 临床表现 内分泌变化 Polycystic ovarian syndrome Clinical manifestation Endocrine change
  • 相关文献

参考文献20

  • 1李蓉,曾玖芝,杜昂鹰.二甲双胍联合达英-35治疗多囊卵巢综合征的临床研究[J].四川医学,2012,33(2):207-209. 被引量:35
  • 2杨丽霞.达英-35联合二甲双胍对多囊卵巢综合征患者血清胰岛素与性激素的影响[J].中国实用医刊,2012,39(9):116-116. 被引量:14
  • 3王松.达英-35联合二甲双胍治疗多囊卵巢综合症内分泌代谢紊乱分析[J].中国保健营养(上旬刊),2014,24(3):523-524.
  • 4Baracat MC,Serafini PC,Sim?es Rdos S,et al.Systematic review of cell adhesion molecules and estrogen receptor expression in the endometrium of patients with polycystic ovary syndrome[J].Int J Gynaecol Obstet,2015,129(1):1-4.
  • 5代晶芳,李晓林,孙宝治.多囊卵巢综合征易感基因多态性的研究进展[J].山东医药,2013,53(34):98-101. 被引量:18
  • 6Chua AK,Azziz R,Goodarzi MO.Association study of CYP17 and HSD11B1 in polyeystic ovary syndrome utilizing comprehensive gene coverage[J].Mol Hum Reprod,2012,18(6):320-324.
  • 7Lecke SB,Morsch DM,Spritzer PM.CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome[J].Steroids,2011,76(12):1383-1388.
  • 8张新林,张成伟,王勇.多囊卵巢综合征的基因多态性研究进展[J].国际妇产科学杂志,2012,39(2):125-128. 被引量:12
  • 9Gu BH,Park JM,Back KH.Genetic variations of follicle stimulating hormone receptor are associated with polyeystic ovary syndrome[J].Int J Mol Med,2010,26(1):107-112.
  • 10Kim JW,Lee MH,Park JE,et al.Association of IL-18 genotype with impaired glucose regulation in Korean women with polyeystic ovary syndrome[J].Eur J Obstet Gynecol Reprod Biol,2012,161(1):51-55.

二级参考文献102

共引文献152

同被引文献110

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部